Truist analyst David MacDonald lowered the firm’s price target on Community Health (CYH) to $3 from $3.50 and keeps a Hold rating on the shares after its Q1 results. Adjusted EBITDA landed below consensus and volumes were modestly negative across the board, though the management continues to target low single-digit growth in 2026, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CYH:
- Community Health Systems Launches $600 Million Debt Tender
- Community Health price target lowered to $3 from $3.50 at Barclays
- Community Health Systems Balances Debt Cuts With Weak Q1
- Community Health Reports Wider Loss Amid Portfolio Rationalization
- Community Health reports Q1 EPS (43c), consensus (9c)